T1	Participants 425 656	In a population-based screening program in Sweden, 12,527 women 32 to 38 years of age were randomly assigned at a 1:1 ratio to have an HPV test plus a Papanicolaou (Pap) test (intervention group) or a Pap test alone (control group)
T2	Participants 47 73	screen for cervical cancer
T3	Participants 1336 1459	women in the intervention group who were found to have lesions of grade 2 or 3 cervical intraepithelial neoplasia or cancer
T4	Participants 2114 2166	to screen women in their mid-30s for cervical cancer
T5	Participants 1934 1969	Women with persistent HPV infection
T6	Participants 2179 2249	incidence of grade 2 or 3 cervical intraepithelial neoplasia or cancer
